Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter

Abstract Dopamine transporter (DAT) is the target of cocaine and HIV-1 transactivator of transcription (Tat) protein. Identifying allosteric modulatory molecules with potential attenuation of cocaine and Tat binding to DAT are of great scientific and clinical interest. We demonstrated that tyrosine...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wei-Lun Sun, Pamela M. Quizon, Yaxia Yuan, Wei Zhang, Subramaniam Ananthan, Chang-Guo Zhan, Jun Zhu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3369cf4f839a46018464e3a5d48ef71e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3369cf4f839a46018464e3a5d48ef71e
record_format dspace
spelling oai:doaj.org-article:3369cf4f839a46018464e3a5d48ef71e2021-12-02T16:06:58ZAllosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter10.1038/s41598-017-03771-02045-2322https://doaj.org/article/3369cf4f839a46018464e3a5d48ef71e2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-03771-0https://doaj.org/toc/2045-2322Abstract Dopamine transporter (DAT) is the target of cocaine and HIV-1 transactivator of transcription (Tat) protein. Identifying allosteric modulatory molecules with potential attenuation of cocaine and Tat binding to DAT are of great scientific and clinical interest. We demonstrated that tyrosine 470 and 88 act as functional recognition residues in human DAT (hDAT) for Tat-induced inhibition of DA transport and transporter conformational transitions. Here we investigated the allosteric modulatory effects of two allosteric ligands, SRI-20041 and SRI-30827 on cocaine binding on wild type (WT) hDAT, Y470 H and Y88 F mutants. Effect of SRI-30827 on Tat-induced inhibition of [3H]WIN35,428 binding was also determined. Compared to a competitive DAT inhibitor indatraline, both SRI-compounds displayed a similar decrease (30%) in IC50 for inhibition of [3H]DA uptake by cocaine in WT hDAT. The addition of SRI-20041 or SRI-30827 following cocaine slowed the dissociation rate of [3H]WIN35,428 binding in WT hDAT relative to cocaine alone. Moreover, Y470H and Y88F hDAT potentiate the inhibitory effect of cocaine on DA uptake and attenuate the effects of SRI-compounds on cocaine-mediated dissociation rate. SRI-30827 attenuated Tat-induced inhibition of [3H]WIN35,428 binding. These observations demonstrate that tyrosine 470 and 88 are critical for allosteric modulatory effects of SRI-compounds on the interaction of cocaine with hDAT.Wei-Lun SunPamela M. QuizonYaxia YuanWei ZhangSubramaniam AnanthanChang-Guo ZhanJun ZhuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Wei-Lun Sun
Pamela M. Quizon
Yaxia Yuan
Wei Zhang
Subramaniam Ananthan
Chang-Guo Zhan
Jun Zhu
Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter
description Abstract Dopamine transporter (DAT) is the target of cocaine and HIV-1 transactivator of transcription (Tat) protein. Identifying allosteric modulatory molecules with potential attenuation of cocaine and Tat binding to DAT are of great scientific and clinical interest. We demonstrated that tyrosine 470 and 88 act as functional recognition residues in human DAT (hDAT) for Tat-induced inhibition of DA transport and transporter conformational transitions. Here we investigated the allosteric modulatory effects of two allosteric ligands, SRI-20041 and SRI-30827 on cocaine binding on wild type (WT) hDAT, Y470 H and Y88 F mutants. Effect of SRI-30827 on Tat-induced inhibition of [3H]WIN35,428 binding was also determined. Compared to a competitive DAT inhibitor indatraline, both SRI-compounds displayed a similar decrease (30%) in IC50 for inhibition of [3H]DA uptake by cocaine in WT hDAT. The addition of SRI-20041 or SRI-30827 following cocaine slowed the dissociation rate of [3H]WIN35,428 binding in WT hDAT relative to cocaine alone. Moreover, Y470H and Y88F hDAT potentiate the inhibitory effect of cocaine on DA uptake and attenuate the effects of SRI-compounds on cocaine-mediated dissociation rate. SRI-30827 attenuated Tat-induced inhibition of [3H]WIN35,428 binding. These observations demonstrate that tyrosine 470 and 88 are critical for allosteric modulatory effects of SRI-compounds on the interaction of cocaine with hDAT.
format article
author Wei-Lun Sun
Pamela M. Quizon
Yaxia Yuan
Wei Zhang
Subramaniam Ananthan
Chang-Guo Zhan
Jun Zhu
author_facet Wei-Lun Sun
Pamela M. Quizon
Yaxia Yuan
Wei Zhang
Subramaniam Ananthan
Chang-Guo Zhan
Jun Zhu
author_sort Wei-Lun Sun
title Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter
title_short Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter
title_full Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter
title_fullStr Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter
title_full_unstemmed Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter
title_sort allosteric modulatory effects of sri-20041 and sri-30827 on cocaine and hiv-1 tat protein binding to human dopamine transporter
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/3369cf4f839a46018464e3a5d48ef71e
work_keys_str_mv AT weilunsun allostericmodulatoryeffectsofsri20041andsri30827oncocaineandhiv1tatproteinbindingtohumandopaminetransporter
AT pamelamquizon allostericmodulatoryeffectsofsri20041andsri30827oncocaineandhiv1tatproteinbindingtohumandopaminetransporter
AT yaxiayuan allostericmodulatoryeffectsofsri20041andsri30827oncocaineandhiv1tatproteinbindingtohumandopaminetransporter
AT weizhang allostericmodulatoryeffectsofsri20041andsri30827oncocaineandhiv1tatproteinbindingtohumandopaminetransporter
AT subramaniamananthan allostericmodulatoryeffectsofsri20041andsri30827oncocaineandhiv1tatproteinbindingtohumandopaminetransporter
AT changguozhan allostericmodulatoryeffectsofsri20041andsri30827oncocaineandhiv1tatproteinbindingtohumandopaminetransporter
AT junzhu allostericmodulatoryeffectsofsri20041andsri30827oncocaineandhiv1tatproteinbindingtohumandopaminetransporter
_version_ 1718384768072024064